NO20020044L - Terapeutisk middel for legemiddel-resistent hyperkalsemi - Google Patents

Terapeutisk middel for legemiddel-resistent hyperkalsemi

Info

Publication number
NO20020044L
NO20020044L NO20020044A NO20020044A NO20020044L NO 20020044 L NO20020044 L NO 20020044L NO 20020044 A NO20020044 A NO 20020044A NO 20020044 A NO20020044 A NO 20020044A NO 20020044 L NO20020044 L NO 20020044L
Authority
NO
Norway
Prior art keywords
hypercalcaemia
drug
resistant
therapeutic agent
therapeutic
Prior art date
Application number
NO20020044A
Other languages
English (en)
Norwegian (no)
Other versions
NO20020044D0 (no
Inventor
Hidemi Saito
Toshiaki Tsunenari
Etsuro Onuma
Original Assignee
Chugai Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chugai Pharmaceutical Co Ltd filed Critical Chugai Pharmaceutical Co Ltd
Publication of NO20020044D0 publication Critical patent/NO20020044D0/no
Publication of NO20020044L publication Critical patent/NO20020044L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/29—Parathyroid hormone, i.e. parathormone; Parathyroid hormone-related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/18—Drugs for disorders of the endocrine system of the parathyroid hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/18—Drugs for disorders of the endocrine system of the parathyroid hormones
    • A61P5/20—Drugs for disorders of the endocrine system of the parathyroid hormones for decreasing, blocking or antagonising the activity of PTH

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Endocrinology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Rheumatology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO20020044A 1999-07-06 2002-01-04 Terapeutisk middel for legemiddel-resistent hyperkalsemi NO20020044L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP19227099 1999-07-06
PCT/JP2000/004523 WO2001002012A1 (fr) 1999-07-06 2000-07-06 Remedes contre l'hypercalcemie chimio-resistante

Publications (2)

Publication Number Publication Date
NO20020044D0 NO20020044D0 (no) 2002-01-04
NO20020044L true NO20020044L (no) 2002-03-01

Family

ID=16288493

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20020044A NO20020044L (no) 1999-07-06 2002-01-04 Terapeutisk middel for legemiddel-resistent hyperkalsemi

Country Status (17)

Country Link
EP (1) EP1195164A4 (fr)
KR (1) KR20020040743A (fr)
CN (1) CN1399557A (fr)
AR (1) AR020867A1 (fr)
AU (1) AU5849700A (fr)
BR (1) BR0012467A (fr)
CA (1) CA2373945A1 (fr)
CZ (1) CZ20014730A3 (fr)
HK (1) HK1046235A1 (fr)
HU (1) HUP0202218A3 (fr)
MX (1) MXPA02000018A (fr)
NO (1) NO20020044L (fr)
PL (1) PL353407A1 (fr)
RU (1) RU2002102916A (fr)
SK (1) SK162002A3 (fr)
WO (1) WO2001002012A1 (fr)
ZA (1) ZA200200264B (fr)

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH02207099A (ja) * 1989-02-07 1990-08-16 Tonen Corp ＰＴＨｒＰ関連ペプチド、その製造法及び用途
CA2035179C (fr) * 1990-01-31 2001-08-14 Gerald S. Brenner Composition pharmaceutique contenant des sels insolubles d'acides biphosphonique
JPH04228089A (ja) * 1990-05-15 1992-08-18 Kanegafuchi Chem Ind Co Ltd 高カルシウム血症治療・予防剤
WO1992000753A1 (fr) * 1990-07-13 1992-01-23 The Regents Of The University Of California Analogues de parathormone modifies aux positions 3, 6 ou 9
DE69233472T2 (de) * 1991-04-05 2006-02-09 The General Hospital Corp., Charlestown Parathormonrezeptor und dafür codierende DNA
US5849695A (en) * 1993-01-13 1998-12-15 The Regents Of The University Of California Parathyroid hormone analogues useful for treatment of osteoporosis and disorders of calcium meatabolism in mammals
JP3504697B2 (ja) * 1993-09-30 2004-03-08 株式会社先端生命科学研究所 ＰＴＨｒＰアンタゴニスト活性を有するポリペプチド及びそれを含むカルシウム代謝治療薬
CO4410206A1 (es) * 1994-07-28 1997-01-09 Sandoz Ag DERIVADOS DE PTH o PTHrP, SU PREPARACION Y COMPOSICIONES FARMACEUTICAS QUE LAS COMPRENDEN
DE69637481T2 (de) * 1995-04-27 2009-04-09 Amgen Fremont Inc. Aus immunisierten Xenomäusen stammende menschliche Antikörper gegen IL-8
KR100847441B1 (ko) * 1996-09-26 2008-07-21 츄가이 세이야꾸 가부시키가이샤 인간의 부갑상선 호르몬 관련 펩티드에 대한 항체
JP4372240B2 (ja) * 1997-05-15 2009-11-25 中外製薬株式会社 悪液質治療剤
MXPA00012770A (es) * 1998-06-26 2003-07-14 Chugai Pharmaceutical Co Ltd Agente terapeutico para crisis hipercalcemica.
TWI255718B (en) * 1999-07-02 2006-06-01 Chugai Pharmaceutical Co Ltd Ameliorative agent for low vasopressin concentration

Also Published As

Publication number Publication date
MXPA02000018A (es) 2003-07-21
CN1399557A (zh) 2003-02-26
SK162002A3 (en) 2002-06-04
PL353407A1 (en) 2003-11-17
EP1195164A1 (fr) 2002-04-10
BR0012467A (pt) 2002-06-11
HK1046235A1 (en) 2003-01-03
RU2002102916A (ru) 2003-11-10
HUP0202218A2 (en) 2002-10-28
NO20020044D0 (no) 2002-01-04
KR20020040743A (ko) 2002-05-30
AR020867A1 (es) 2002-05-29
WO2001002012A1 (fr) 2001-01-11
WO2001002012A8 (fr) 2002-06-06
EP1195164A4 (fr) 2005-09-28
ZA200200264B (en) 2003-04-30
CA2373945A1 (fr) 2001-01-11
HUP0202218A3 (en) 2005-01-28
AU5849700A (en) 2001-01-22
CZ20014730A3 (cs) 2002-04-17

Similar Documents

Publication Publication Date Title
NO20021329D0 (no) Kinaseinhibitorer som terapeutiske midler
EP1296697A4 (fr) Agents therapeutiques - i
DK1212327T3 (da) Pyrazolopyrimidiner som terapeutiske midler
NO20022692D0 (no) Terapeutiske midler
DK1637127T3 (da) Terapeutisk mikroskum
DK1250047T3 (da) Herbicidt middel
EP1196852A4 (fr) Agent d'approvisionnement de tete de station
PT1485127E (pt) Administração de agentes para o tratamento de inflamação
NO20014490D0 (no) Medisinske blandinger
NO995823L (no) Terapeutisk middel for ereksjonsdysfunksjon
PT1206436E (pt) Retinoides para o tratamento de enfisema
NO20014926L (no) Farmasöytiske forbindelser
FR2802423B1 (fr) Compositions pharmaceutiques
DK1231840T3 (da) Anti-angiogent cellulært middel til cancerterapi
NO20016430L (no) Farmasöytisk kompleks
NO20021976D0 (no) Selektiv leverterapi
NO20012226L (no) Terapeutiske midler for medikamentavhengighet
NO20016301D0 (no) Terapeutiske midler
NO20020044L (no) Terapeutisk middel for legemiddel-resistent hyperkalsemi
DK1224181T3 (da) Substituerede pyrroler som antiproliferative midler til behandling af cancer
DK1020430T3 (da) Middel indeholdende L-carnitin
NO20034356D0 (no) Terapeutisk middel for overaktiv bl¶re
DK1305314T3 (da) Krystallinsk terapeutisk middel
SE0103855D0 (sv) Therapeutic agents
SE0103854D0 (sv) Therapeutic agents